Evaluation of the Synuclein-γ (SNCG) Gene as a PPARγ Target in Murine Adipocytes, Dorsal Root Ganglia Somatosensory Neurons, and Human Adipose Tissue

Recent evidence in adipocytes points to a role for synuclein-γ in metabolism and lipid droplet dynamics, but interestingly this factor is also robustly expressed in peripheral neurons. Specific regulation of the synuclein-γ gene (Sncg) by PPARγ requires further evaluation, especially in peripheral neurons, prompting us to test if Sncg is a bona fide PPARγ target in murine adipocytes and peripheral somatosensory neurons derived from the dorsal root ganglia (DRG). Sncg mRNA was decreased in 3T3-L1 adipocytes (~68%) by rosiglitazone, and this effect was diminished by the PPARγ antagonist T0070907. Chromatin immunoprecipitation experiments confirmed PPARγ protein binding at two promoter sequences of Sncg during 3T3-L1 adipogenesis. Rosiglitazone did not affect Sncg mRNA expression in murine cultured DRG neurons. In subcutaneous human WAT samples from two cohorts treated with pioglitazone (>11 wks), SNCG mRNA expression was reduced, albeit highly variable and most evident in type 2 diabetes. Leptin (Lep) expression, thought to be coordinately-regulated with Sncg based on correlations in human adipose tissue, was also reduced in 3T3-L1 adipocytes by rosiglitazone. However, Lep was unaffected by PPARγ antagonist, and the LXR agonist T0901317 significantly reduced Lep expression (~64%) while not impacting Sncg. The results support the concept that synuclein-γ shares some, but not all, gene regulators with leptin and is a PPARγ target in adipocytes but not DRG neurons. Regulation of synuclein-γ by cues such as PPARγ agonism in adipocytes is logical based on recent evidence for an important role for synuclein-γ in the maintenance and dynamics of adipocyte lipid droplets.

[1]  C. Shou,et al.  Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients , 2016, BMC Cancer.

[2]  S. Adams,et al.  Relations between metabolic homeostasis, diet, and peripheral afferent neuron biology. , 2014, Advances in nutrition.

[3]  A. Bookout,et al.  PPARγ in vagal neurons regulates high-fat diet induced thermogenesis. , 2014, Cell metabolism.

[4]  M. Nagamine,et al.  Cross-sensitization of histamine-independent itch in mouse primary sensory neurons , 2012, Neuroscience.

[5]  I. Guschina,et al.  Increased lipolysis and altered lipid homeostasis protect γ-synuclein–null mutant mice from diet-induced obesity , 2012, Proceedings of the National Academy of Sciences.

[6]  Jamey D. Young,et al.  PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation , 2012, Cell Death and Disease.

[7]  A. Szántó,et al.  Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response. , 2012, Physiological reviews.

[8]  Y. Uehara,et al.  Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: findings from in vitro and ex vivo studies. , 2011, Atherosclerosis.

[9]  E. Carboni,et al.  Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model , 2011, Neuroscience.

[10]  Y. Shrestha,et al.  Characterization of a novel melanocortin receptor-containing node in the SNS outflow circuitry to brown adipose tissue involved in thermogenesis , 2011, Brain Research.

[11]  H. Raybould,et al.  Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. , 2011, American journal of physiology. Endocrinology and metabolism.

[12]  J. Olefsky,et al.  Brain PPARγ Promotes Obesity and is Required for the Insulin–Sensitizing Effect of Thiazolidinediones , 2011, Nature Medicine.

[13]  J. Harwood,et al.  Lipid Classes and Fatty Acid Patterns are Altered in the Brain of γ-Synuclein Null Mutant Mice , 2010, Lipids.

[14]  C. K. Song,et al.  Sympathetic and sensory innervation of brown adipose tissue , 2010, International Journal of Obesity.

[15]  T. Südhof,et al.  α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro , 2010, Science.

[16]  N. Calcutt,et al.  Diet‐induced obesity in Sprague–Dawley rats causes microvascular and neural dysfunction , 2010, Diabetes/metabolism research and reviews.

[17]  Y. Shrestha,et al.  Sensory and sympathetic nervous system control of white adipose tissue lipolysis , 2010, Molecular and Cellular Endocrinology.

[18]  Dorothy D. Sears,et al.  Molecular Characterization of the Tumor Suppressor Candidate 5 Gene: Regulation by PPARγ and Identification of TUSC5 Coding Variants in Lean and Obese Humans , 2010, PPAR research.

[19]  Jan Nedergaard,et al.  Chronic Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation of Epididymally Derived White Adipocyte Cultures Reveals a Population of Thermogenically Competent, UCP1-containing Adipocytes Molecularly Distinct from Classic Brown Adipocytes* , 2009, The Journal of Biological Chemistry.

[20]  Jon W. Huss,et al.  BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources , 2009, Genome Biology.

[21]  Dorothy D. Sears,et al.  Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization , 2009, Proceedings of the National Academy of Sciences.

[22]  J. Newman,et al.  Increased expression of receptors for orexigenic factors in nodose ganglion of diet-induced obese rats. , 2009, American journal of physiology. Endocrinology and metabolism.

[23]  C. K. Song,et al.  Anterograde transneuronal viral tract tracing reveals central sensory circuits from white adipose tissue. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[24]  E. Kalkhoven,et al.  Posttranslational Modifications of PPAR‐γ: Fine‐tuning the Metabolic Master Regulator , 2009, Obesity.

[25]  H. Raybould.  Nutrient sensing in the gastrointestinal tract: Possible role for nutrient transporters , 2008, Journal of Physiology and Biochemistry.

[26]  N. Kiguchi,et al.  Pioglitazone attenuates tactile allodynia and microglial activation in mice with peripheral nerve injury. , 2008, Drug discoveries & therapeutics.

[27]  S. O’Rahilly,et al.  Novel Leptin-Regulated Genes Revealed by Transcriptional Profiling of the Hypothalamic Paraventricular Nucleus , 2008, The Journal of Neuroscience.

[28]  Peter Tontonoz,et al.  Fat and beyond: the diverse biology of PPARgamma. , 2008, Annual review of biochemistry.

[29]  A. Surguchov,et al.  γ-Synuclein: Cell-Type-Specific Promoter Activity and Binding to Transcription Factors , 2008, Journal of Molecular Neuroscience.

[30]  K. Clément,et al.  γ-Synuclein Is an Adipocyte-Neuron Gene Coordinately Expressed with Leptin and Increased in Human Obesity , 2008, The Journal of nutrition.

[31]  N. Inestrosa,et al.  Peroxisome Proliferator-activated Receptor γ Up-regulates the Bcl-2 Anti-apoptotic Protein in Neurons and Induces Mitochondrial Stabilization and Protection against Oxidative Stress and Apoptosis* , 2007, Journal of Biological Chemistry.

[32]  J. Nadler,et al.  High-Fat Diet–Induced Neuropathy of Pre-Diabetes and Obesity , 2007, Diabetes.

[33]  T. Baumann,et al.  Characterization of Tusc5, an adipocyte gene co-expressed in peripheral neurons , 2007, Molecular and Cellular Endocrinology.

[34]  D. Resnick,et al.  Thiazolidinedione Class of Peroxisome Proliferator-Activated Receptor γ Agonists Prevents Neuronal Damage, Motor Dysfunction, Myelin Loss, Neuropathic Pain, and Inflammation after Spinal Cord Injury in Adult Rats , 2007, Journal of Pharmacology and Experimental Therapeutics.

[35]  S. Liatis,et al.  Sympathetic System Activity in Obesity and Metabolic Syndrome , 2006, Annals of the New York Academy of Sciences.

[36]  Han-Woong Lee,et al.  Chromatin Remodeling Complex Interacts with ADD1/SREBP1c To Mediate Insulin-Dependent Regulation of Gene Expression , 2006, Molecular and Cellular Biology.

[37]  Danielle G. Lemay,et al.  Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics s⃞ Published, JLR Papers in Press, April 3, 2006. , 2006, Journal of Lipid Research.

[38]  J. Petrofsky,et al.  The impact of rosiglitazone on heat tolerance in patients with type 2 diabetes. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[39]  U. Smith,et al.  The effect of PPARγ ligands on the adipose tissue in insulin resistance , 2005 .

[40]  Scott W. Lee,et al.  Gait characteristics in patients with type 2 diabetes; improvement after administration of rosiglitazone. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[41]  Ka Wan Li,et al.  Differential Transport and Local Translation of Cytoskeletal, Injury-Response, and Neurodegeneration Protein mRNAs in Axons , 2005, The Journal of Neuroscience.

[42]  G. Bray,et al.  The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo. , 2004, Diabetes care.

[43]  J. Gustafsson,et al.  Putative metabolic effects of the liver X receptor (LXR). , 2004, Diabetes.

[44]  A. Davies,et al.  Neurons Expressing the Highest Levels of γ-Synuclein Are Unaffected by Targeted Inactivation of the Gene , 2003, Molecular and Cellular Biology.

[45]  Jong Bae Seo,et al.  Functional Characterization of the Human Resistin Promoter with Adipocyte Determination- and Differentiation-Dependent Factor 1/Sterol Regulatory Element Binding Protein 1c and CCAAT Enhancer Binding Protein-α , 2003 .

[46]  J. Gustafsson,et al.  On the role of liver X receptors in lipid accumulation in adipocytes. , 2003, Molecular endocrinology.

[47]  M. Fini,et al.  Effect of γ-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells , 2003 .

[48]  Jingwen Liu,et al.  Blockade of AP1 Transactivation Abrogates the Abnormal Expression of Breast Cancer-specific Gene 1 in Breast Cancer Cells* , 2002, The Journal of Biological Chemistry.

[49]  David E. Misek,et al.  Microarray Analyses during Adipogenesis: Understanding the Effects of Wnt Signaling on Adipogenesis and the Roles of Liver X Receptor α in Adipocyte Metabolism , 2002, Molecular and Cellular Biology.

[50]  Yang Li,et al.  T0070907, a Selective Ligand for Peroxisome Proliferator-activated Receptor γ, Functions as an Antagonist of Biochemical and Cellular Activities* , 2002, The Journal of Biological Chemistry.

[51]  Wei Chen,et al.  Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. , 2001, Diabetes.

[52]  M. A. Baak.  The peripheral sympathetic nervous system in human obesity , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[53]  J. Born,et al.  Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. , 2000, The Journal of clinical endocrinology and metabolism.

[54]  J Q Trojanowski,et al.  Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Liu,et al.  Stimulation of breast cancer invasion and metastasis by synuclein gamma. , 1999, Cancer research.

[56]  A. Davies,et al.  Persyn, a Member of the Synuclein Family, Has a Distinct Pattern of Expression in the Developing Nervous System , 1998, The Journal of Neuroscience.

[57]  A. Dehejia,et al.  Genomic organization and expression of the human β-synuclein gene (SNCB) , 1998 .

[58]  Jimi Adu,et al.  Persyn, a member of the synuclein family, influences neurofilament network integrity , 1998, Nature Neuroscience.

[59]  J. Flier,et al.  Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin. , 1997, The Journal of biological chemistry.

[60]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[61]  B. Spiegelman,et al.  Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor , 1994, Cell.

[62]  N. Kiguchi,et al.  Pioglitazone attenuates tactile allodynia and thermal hyperalgesia in mice subjected to peripheral nerve injury. , 2008, Journal of pharmacological sciences.

[63]  J. Yi,et al.  Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. , 2008, Frontiers in bioscience : a journal and virtual library.

[64]  U. Smith,et al.  The effect of PPARgamma ligands on the adipose tissue in insulin resistance. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[65]  M. Fini,et al.  Effect of gamma-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells. , 2003, Archives of biochemistry and biophysics.

[66]  Jong Bae Seo,et al.  Functional characterization of the human resistin promoter with adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element binding protein 1c and CCAAT enhancer binding protein-alpha. , 2003, Molecular endocrinology.

[67]  R. Evans,et al.  A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. , 2001, Molecular cell.

[68]  R. Evans,et al.  A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis , 2001 .

[69]  V. Giguère.  Orphan nuclear receptors: from gene to function. , 1999, Endocrine reviews.

[70]  A. Dehejia,et al.  Genomic organization and expression of the human beta-synuclein gene (SNCB). , 1998, Genomics.

[71]  B. Spiegelman,et al.  Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. , 1994, Cell.